Synergism between hydrogen sulfide (H(2)S) and nitric oxide (NO) in vasorelaxation induced by stonustoxin (SNTX), a lethal and hypotensive protein factor isolated from stonefish Synanceja horrida venom

Life Sci. 2007 Apr 10;80(18):1664-8. doi: 10.1016/j.lfs.2007.01.058. Epub 2007 Feb 13.

Abstract

Stonustoxin (SNTX) is a 148 kDa, dimeric, hypotensive and lethal protein factor isolated from the venom of the stonefish Synanceja horrida. SNTX (10-320 ng/ml) progressively causes relaxation of endothelium-intact, phenylephrine (PE)-precontracted rat thoracic aortic rings. The SNTX-induced vasorelaxation was inhibited by L-N(G)-nitro arginine methyl ester (L-NAME), suggesting that nitric oxide (NO) contributes to the SNTX-induced response. Interestingly, D, L-proparglyglycine (PAG) and beta-cyano-L-alanine (BCA), irreversible and competitive inhibitors of cystathionine-gamma-lyase (CSE) respectively, also inhibited SNTX-induced vasorelaxation, indicating that H(2)S may also play a part in the effect of SNTX. The combined use of L-NAME with PAG or BCA showed that H(2)S and NO act synergistically in effecting SNTX-induced vasorelaxation.

MeSH terms

  • Animals
  • Aorta, Thoracic / metabolism*
  • Cystathionine gamma-Lyase / antagonists & inhibitors
  • Enzyme Inhibitors / pharmacology
  • Fish Venoms / isolation & purification
  • Fish Venoms / pharmacology*
  • Fishes, Poisonous
  • Hydrogen Sulfide / agonists*
  • Hydrogen Sulfide / metabolism
  • Male
  • Nitric Oxide / agonists*
  • Nitric Oxide / metabolism
  • Organ Culture Techniques
  • Phenylephrine / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects*

Substances

  • Enzyme Inhibitors
  • Fish Venoms
  • Vasoconstrictor Agents
  • stonustoxin
  • Phenylephrine
  • Nitric Oxide
  • Cystathionine gamma-Lyase
  • Hydrogen Sulfide